Status of the Microfluidics Industry 2024

Report's objectives

This Yole Intelligence report is an updated version of the 2023 report providing a complete analysis of microfluidic device/module applications, markets, and technologies.

His new version provides:

• New significant trends and evolution in the microfluidic industry markets, applications, and business models
• Presentation of the hot spots where things are moving, along with future high-potential applications
• Analysis of strategic moves since 2021 (post-COVID pandemic period): mergers and acquisitions, fundraising, etc.
• Understanding of the competitive environment with an overview of key players, the evolution of microfluidic vendors’ market shares per segment, and fabs’ market shares
• Updated market data and forecast up to 2029, in value and volume for microfluidic devices and modules, with insights on the materials market (polymer, PDMS, glass wafers, silicon wafers)
• Supply chain description and analysis
• Latest technology trends (materials, manufacturing, biology, biosensors, etc.)

This report thoroughly summarizes the 2023 microfluidics market, considering the trends for each application. The report was finalized in mid-June 2024, so the data is the latest available.

Key Features 

• Market segmentation, data, and forecasts for 2024 - 2029, by devices and modules, in units and dollars, including materials ratio.
• A detailed explanation of current and future market trends, covering several applications of microfluidic technologies.
• Market share at the module and fab level, In comparison to the last two years, explaining the dynamics.
• Fundraising and M&A analysis to help understand the ecosystem’s dynamics.
• Description of the supply chain involving various players as a function of the materials used.
• Materials, manufacturing, and other technology trends, along with roadmaps.

What’s new?

• Inkjet printing technologies were added.
• Focus on market trends related to Consumer, industrial, and medical markets.
• Analysis and forecast by type of microfluidic modules.

Microfluidics has the potential to address future challenges.

The microfluidics module market is expected to grow from $18 billion in 2023 to almost $22 billion by 2029, with a CAGR of 2.6%. During the pandemic, the demand for diagnostic tests and SARS-CoV-2 sequencing drove market growth. In terms of shipments, 1.15 billion units are expected to be sold in 2029, maintaining a stable volume compared to 2023. The consumer market, dominated by printing technologies, sees HP facing declining demand due to increased digitization and affordable ink tank printers. In diagnostics, Cue Health leads but faces a declining market post-COVID-19, with future growth potentially from wellness and health monitoring solutions by companies like Withings and Epicore Biosystems. Despite global economic challenges, the industrial market is growing, especially in environmental, food safety, agriculture, and oil testing, with electronic cooling being a particularly promising application. The pharmaceutical and life science research segment is the most dynamic, projected to grow at a CAGR of 5.1%, driven by advancements in drug discovery, sepsis diagnostics, next-generation sequencing, microphysiological systems, and cell analysis.

Finding the right place at the right moment after a market decline.

Almost 91% of the microfluidic market is dominated by ten major players, led by diagnostics companies specializing in various biological tests. Cepheid outperformed Illumina in 2022 and 2023 due to its high number of installed instruments and strong presence in respiratory testing. Companies like bioMérieux, Abbott, and Roche Diagnostics saw flat growth in 2023. A total of $0.97 billion was raised in funding in 2023, with a clear trend towards technologies related to cell therapy, analysis, culture, and diagnostics. The market is in a transition phase post-COVID-19, with major players expected to invest in new opportunities and smaller companies facing critical decisions about expansion or acquisition.

Bringing intelligence closer to the point of need.

The microfluidics market is primarily driven by diagnostics applications, with polymers being the main material for manufacturing single-use devices. However, the market also utilizes silicon, especially in the mature inkjet printing technology, which reduces costs through semiconductor manufacturing processes. These processes are used to produce NGS flow cells with glass and silicon-based biosensors, enhancing intelligence at the module level. There are emerging projects in cell analysis, proteomics, and point-of-care diagnostics including Sarcura's photonic sensors for cell therapy and SiPhox's photonic sensor for home testing. Looking ahead, the rise of generative AI will increase the need for chip cooling solutions, where silicon-based microfluidics could provide efficient cooling by integrating with semiconductor processes. This would allow direct cooling of electronic devices at the chip level, addressing significant market volumes. However, challenges remain, such as developing effective methods for liquid flow control in highly parallelized systems.

• Glossary
• Table of contents
• Identity card
• Report objectives
• Scope of the report
• Methodologies & definition
• About the author
• Companies cited
• Historical forecasts
• What we got right, what we got wrong
• 3-page summary
• Executive summary
• Context
• Market data and forecasts
  • Market data and forecast by end-markets
  • Market data and forecast by applications
  • Market data and forecast by module types
  • Market data and forecast by materials
  • Market trends – Conclusions
• Market trends
  • Consumer market trends
  • Industrial market trends
  • Medical market trends
  • Market trends- Conclusions
• Market shares & supply chain
  • Market shares – Vendors
  • Market shares – Fabs
  • Fundraisings and M&As
  • Supply chain
• Technology trends
  • Development of biosensors
  • Materials
  • Manufacturing
    • Polymer manufacturing
    • Silicon / Glass manufacturing
    • Backend processes
  • Materials & manufacturing conclusion and trends
• Conclusion & Outlook
• About Yole Group

3M, 5-HT (LTS Lohmann), 10X Genomics, Abbott, Accelix (LeukoDx), Achira Labs, AGC, Agilent Technologies, AgPlus Diagnostics, Akonni Biosystems, ALiA Biotech, Aline inc, Alveo – be.well, Ande Corporation, Arrayit Corporation, Astraveus, Ativa Medical, Atomica (IMT MEMS), AxBio, Axxicon, Baebies, Bartels Mikrotechnik, BD (Becton Dickinson), Berkeley Lights, BforCure, BGI, Bi.Flow Systems, Binx Health, Biocartis, Biomensio, bioMérieux, Bionano Genomics, Bioneer, Bio-Rad, BioSurfit, Biotechne, Boehringer Ingelheim, Bosh Vivalytic, Brüker (NanoString Technologies), CapitalBiotech Corporation, Capsum, Carville, Cellares, CellFE, CDA, Charles River, ClexBio, CN Bio, Cubed Laboratories, Cue Health, Cytovale, Daktari Diagnostics, Danaher (Cepheid, HemoCue, Pall corporation, Beckman Coulter), Deepcell, Dermagnostix, DiaSorin Molecular, DNA electronics (DNAe), DNA Nudge, Dolomite Microfluidics, Element Biosciences, Elveflow (Elvesys), Emulate Bio, ENPLAS, Epicore Biosystems, Epigem, Evonetix, EVG (EV Group), Evonetix, Fast Radius, FEMTOprint, Finnadvance, Fluigent, FluimediX, Fluxergy, Genalyte, Gener8, GenSpeed Biotech, Helvoet, Hesperos, Hicomp, Hochuen Medical, Hologic (Mobidiag), IDEX Health & Science, iLine Microsystems, Illumina, imec, iMiGiNE, IMTAG, Inflammatix, Integra (Microculus), Invetech, InziGn, Isoplexis, Klearia, Kloé, Kypha (Biosensa), LightDeck (Mbio Diagnostics), LioniX, L’Oréal, LuminUltra, Lunaphore Technologies, Medimate (CE-Mate), MedSpray, Mekonos, MeMed, Menarini Silicon Biosystems, Mesa labs (Gyros protein), MGI Tech (BGI Group), Micralyne (Teledyne Dalsa), Microfluidic ChipShop, Micron Biomedical, Micronit, MicrofluidiX, Micropoint Technologies, microTEC, miDiagnostics, Miltenyi Biotec, Mimetas, Mission Bio, MiTAS Chip, Molbio Diagnostics, MZP tech, Nabsys, NanoCellect, NanoDx, NanoEntek, Nanomix, NanoPass, NanoScribe, Netri, Nicoya, Nortis, Nutcracker, Nypro (Jabil), Ondavia, Opgen Group (Curetis), OPKO Diagnostics, Optolane Technologies, Osler Diagnostics, Oxford Nanopore Technologies, Pacific Biosciences (+Omniome), Palamedrix, Paragraf (Cardea), Pattern Bioscience, Perkinelmer (Caliper Life Sciences), Philips Engineering Solutions, Phillips Medisize, PixCell, Plan optik group (Little Things Factory), Plastic Design Corporation, Potomac, Precision Nanosystems, Qiagen, Qorvo Biotechnologies, Quanterix, QuantuMDx, Quantum-Si, QuidelOrtho, Qurin Diagnostics, Qvella Corporation, Rab-Microfluidics, Radisens Diagnostics, Randox Laboratories, Rapid Fluidics, RedShift Bio, Rheonix, Roche (Genmark Diagnostics, lumiraDx), Rogue Valley Microdevices, Roswell Biotechnologies, rqmicro, Sandstone Diagnostics, Sarcura, Sartorius, Schott (MiniFAB), Schlumberger, SD Biosensor (Meridian Biosciences), Sekisui (Veredus laboratories), SensoDx, Sherlock Biosciences (Sense bio), Siemens Healthineers, Sight Diagnostics, Silex Microsystems, Singular genomics, SiPhox, SkyWater Technology Foundry, Smiths Detection (Pathsensors), SpinChip Diagnostics, Standard BioTools (Fluidigm), Stilla Technologies, STMicroelectronics, Stratec Consumables (Natech Plastics), Surfix Diagnostics, SynVivo, Syrris, Sysmex, T2 Biosystems, Takara bio, Talis Biomedical, TearLab, Tecnisco, TE Connectivity (microLIQUID, Wi, Toolbox Medical Innovations), Thermo Fisher Scientific (Olink), Thinkcyte, TissUse, Translume, Trilobite, TDK Tronics, Truvian Sciences, TSMC, uFluidix, Vantiva precision biosystems (Technicolor), Vaxxas, Vela Diagnostics (Great basin scientific), Visby medical (Click diagnostics), Volta labs, Vortex Biosciences, VyCAP, WeareCellix, Weidmann Plastics, Wenhao Chip, Werfen (Accriva Diagnostics), Withings, Xfab, Xona Microfluidics, z-microsystems, Zoetis, Zomedica Pharmaceuticals, and more.